Detalles de la búsqueda
1.
Venetoclax in biomarker-selected multiple myeloma patients: Impact of exposure on clinical efficacy and safety.
Hematol Oncol
; 42(1): e3222, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740931
2.
Venetoclax pharmacokinetics in participants with end-stage renal disease undergoing haemodialysis.
Br J Clin Pharmacol
; 90(3): 748-758, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855131
3.
A formal vinylic substitution reaction for the synthesis of α,ß-unsaturated enol esters and their anticancer potential.
Org Biomol Chem
; 22(16): 3273-3278, 2024 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572769
4.
Venetoclax exposure-efficacy and exposure-safety relationships in patients with treatment-naïve acute myeloid leukemia who are ineligible for intensive chemotherapy.
Hematol Oncol
; 40(2): 269-279, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043428
5.
Benzannulation Reactions: A Case for Perspective Change From Arene Decoration to Arene Construction.
Chem Rec
; 22(1): e202100249, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34796605
6.
Recent developments in the chemistry of allenyl sulfones.
Org Biomol Chem
; 18(3): 365-378, 2020 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31830186
7.
Regioselective synthesis of arylsulfonyl heterocycles from bromoallyl sulfones via intramolecular Heck coupling reaction.
Org Biomol Chem
; 18(36): 7188-7192, 2020 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32897285
8.
Optimizing venetoclax dose in combination with low intensive therapies in elderly patients with newly diagnosed acute myeloid leukemia: An exposure-response analysis.
Hematol Oncol
; 37(4): 464-473, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31251400
9.
Nucleophile-Initiated Catalytic and Multicomponent Reactions.
Chem Rec
; 19(2-3): 347-361, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29962078
10.
Facile synthesis of biarylmethanes and tetrasubstituted arenes via a base-mediated [3 + 3] benzannulation reaction of Morita-Baylis-Hillman adducts and unsaturated sulfones.
Org Biomol Chem
; 17(16): 4073-4076, 2019 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30951081
11.
Gold-catalysed regioselective cascade cycloisomerisation reactions of aza-enediynes for the synthesis of substituted benzoisoquinoline derivatives.
Org Biomol Chem
; 17(2): 369-373, 2019 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30556565
12.
Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials.
Eur J Clin Pharmacol
; 75(2): 207-216, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30291369
13.
Use of depth of response to predict progression-free survival in relapsed or refractory multiple myeloma: Evaluation of results from 102 clinical trials.
Hematol Oncol
; 2018 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29672885
14.
Relationship between response rates and median progression-free survival in non-Hodgkin's lymphoma: A meta-analysis of published clinical trials.
Hematol Oncol
; 36(1): 37-43, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28707346
15.
Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.
Xenobiotica
; 48(9): 904-910, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29027832
16.
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model.
J Pharmacokinet Pharmacodyn
; 45(3): 443-456, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427135
17.
Pharmacokinetic Evaluation of Darunavir Administered Once or Twice Daily in Combination with Ritonavir or the Three-Direct-Acting Antiviral Regimen of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults Coinfected with Hepatitis C and Human Immunodeficiency Viruses.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27919899
18.
Relationship between venetoclax exposure, rituximab coadministration, and progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy.
Hematol Oncol
; 35(4): 679-684, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27982454
19.
Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials.
Br J Clin Pharmacol
; 83(3): 527-539, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662429
20.
Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.
Clin Infect Dis
; 62(8): 972-9, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26740513